The first at-home NAD+ subscription. Transdermal patches activated by clinical-grade iontophoresis. Delivered cold every month.
First 500 members lock in founder pricing. No credit card required.
How it works
No clinic visits. No appointment windows. NAD+ therapy the way it should have been from the start.
A dry-ice insulated box lands at your door every month — patches sealed in individual foil pouches, your iontophoresis device, and a usage journal. Cold from our facility to your hands.
Peel a patch, place it on your forearm or upper arm, and connect the iontophoresis device. A gentle low-voltage current drives NAD+ molecules through the skin over a 20–30 minute session. That's it.
The way regular IV NAD+ clients feel — at home, on your schedule. Designed for daily use or three-times-weekly depending on your tier. Track your results in the included journal.
The disruption story
The IV-clinic model was built around clinical infrastructure. We built around you.
| Comparison | NadConcierge | IV Clinic | Oral NAD+ (NR/NMN) |
|---|---|---|---|
| Monthly cost | $149 – $199 / mo | $400 – $1,500 / session | $50 – $100 / mo |
| Setting | Home, your schedule | Clinic appointment required | Home |
| Bioavailability | High (transdermal + iontophoresis) | Highest (direct IV) | Lowest (gut conversion) |
| Convenience | ✓ High | ✗ Chair time, travel | ✓ Easy |
| Cold-chain quality control | ✓ Dry-ice shipped | ✓ Clinical-grade | ✗ Room-temp capsules |
| Recurring monthly access | ✓ Subscription | ✗ Per-visit billing | ✓ Subscription |
| Geographic availability | ✓ All 50 states | ✗ Clinic proximity only | ✓ Ships anywhere |
The science
We explain what the research actually shows — including where the evidence is strong and where it's still emerging.
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every living cell. It drives energy metabolism, DNA repair, sirtuin activation, and mitochondrial function. By age 50, most people have lost roughly 50% of their peak NAD+ levels — a decline increasingly understood as a driver, not just a marker, of aging-related fatigue and cognitive decline (Massudi et al., PLoS One 2012; Verdin, Science 2015).
The problem with NAD+ delivery has always been the molecule itself: it's large (~663 Da), charged, and hydrophilic — meaning passive skin absorption is near-zero. That's why IV clinics have dominated. Until now.
Iontophoresis applies a small, gentle DC electrical current (0.1–0.5 mA/cm²) that drives charged molecules across the skin barrier. This is not experimental technology — it's been FDA-cleared for lidocaine delivery (IontoPatch), dexamethasone in physical therapy, and pilocarpine in cystic fibrosis testing for 50+ years. The same physics that drives those molecules now works for NAD+.
Direct electrical force moves NAD+ ions toward the negative electrode, through the skin barrier.
Bulk solvent flow induced by the current carries additional molecules across the stratum corneum.
The current temporarily reorganizes skin lipids, opening a delivery window that closes when current stops.
Founder pricing
Waitlist members get founder pricing — guaranteed for the life of your subscription. First shipments Q3 2026.
Best for: daily maintenance and those new to NAD+ therapy
Founder rate — locked at signup
Best for: 3x weekly NAD+ sessions with higher-dose patches
Founder rate — locked at signup
Best for: serious longevity practitioners who want the full stack
Founder rate — locked at signup
Inside every shipment
Every element is engineered for potency, safety, and the cleanest possible experience.
The team
We're not supplement marketers. We're practitioners who wanted a better answer for our patients — and built it.
Clinical operator with years of experience running IV NAD+ therapy programs. Saw the limitations of the clinic model firsthand — the cost, the access, the geographic constraint — and built the system she wished existed. NadConcierge is the pivot from treating patients one at a time to serving thousands from home.
We're onboarding a board-certified longevity physician as our named medical advisor. They will review all protocols, marketing language, and customer escalations. Announcement coming at launch. Placeholder — not currently named.
A transdermal delivery researcher with expertise in iontophoretic systems is joining our scientific advisory board. Their role: validate our patch formulation, design our third-party pilot study, and publish results with us. Announcement at launch.
Founder pricing locked, launch alert sent first, and first patch shipment opportunity. No credit card required today.
Watch your inbox — we'll reach out before anyone else when we launch.
We will never sell your data. Unsubscribe anytime. No spam.
Common questions